Advertisement

Enhanced Molecular Biology Capabilities Through Takara Bio

Custom PCR and qPCR manufacturing to meet EMEA contract lab demands

by | Nov 18, 2024

Contract testing laboratories in Europe, the Middle East, and Africa (EMEA) now have access to enhanced molecular biology capabilities through Takara Bio Europe’s expanded Gothenburg facility. The new custom manufacturing lab, operational as of October 1st, specializes in producing PCR and qPCR enzymes with a weekly output of up to 600,000 reactions. This addition ensures faster service, tailored solutions, and sustainable practices tailored to the unique needs of contract testing labs.

Why This Matters for Contract Testing Labs

  • Tailored Offerings: Custom molecular biology products designed to match specific testing requirements.
  • High Throughput: Production capabilities support the high demands of contract testing environments.
  • Faster Service: Reduced delivery times help maintain tight project timelines.
  • Expert Support: Access to technical expertise ensures reliable and accurate results.
  • Sustainability: Localized production reduces the carbon footprint of supplies.

Conclusion:
With its expanded Gothenburg facility, Takara Bio Europe is poised to support the unique challenges of contract testing labs. The site’s customized solutions and sustainable practices represent a significant advancement in molecular biology manufacturing.

This article is an AI generated summary of a published press release provided by Takara Bio

Author

Related Content

Advertisement

Editor's Choice

Advertisement

Advertisement